Published in J Leukoc Biol on February 01, 1989
Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun (1991) 1.21
Phospholipids enhance the binding of peptides to class II major histocompatibility molecules. Proc Natl Acad Sci U S A (1990) 1.05
Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol (1998) 1.75
Role of L3T4+ T cells in host defense against Histoplasma capsulatum. Infect Immun (1988) 1.68
Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect Immun (1997) 1.63
Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest (1994) 1.56
Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J Immunol (1999) 1.54
Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect Immun (1995) 1.44
Modulation of immune responses in murine pulmonary histoplasmosis. J Infect Dis (1997) 1.39
Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect Immun (1998) 1.32
Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun (1991) 1.21
Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun (1991) 1.19
Development and characterization of Histoplasma capsulatum-reactive murine T-cell lines and clones. Infect Immun (1986) 1.16
Regulation of infection with Histoplasma capsulatum by TNFR1 and -2. J Immunol (2000) 1.10
Medical mycology in crisis. J Lab Clin Med (1983) 1.06
An 80-kilodalton antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces cell-mediated immune responses and protection in mice. Infect Immun (1992) 1.06
Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis. J Clin Invest (1998) 1.06
Histoplasma acquisition of calcium and expression of CBP1 during intracellular parasitism. Mol Microbiol (1998) 1.03
Modulation of cellular immune responses in mice with disseminated histoplasmosis by recombinant interleukin-2. Infect Immun (1986) 1.03
Molecular cloning, characterization, and expression of the M antigen of Histoplasma capsulatum. Infect Immun (1999) 1.02
Characterization of antigenic determinants in histoplasmin that stimulate Histoplasma capsulatum-reactive T cells in vitro. Infect Immun (1988) 0.98
The URA5 gene is necessary for histoplasma capsulatum growth during infection of mouse and human cells. Infect Immun (1999) 0.98
Cellular immune responses to recombinant heat shock protein 70 from Histoplasma capsulatum. Infect Immun (1996) 0.97
Stress proteins in fungal diseases. Med Mycol (1998) 0.97
Blastogenic responses to Pneumocystis carinii among patients with human immunodeficiency (HIV) infection. Clin Exp Immunol (1988) 0.95
Development of vaccines and their use in the prevention of fungal infections. Med Mycol (1998) 0.94
V beta 6+ and V beta 4+ T cells exert cooperative activity in clearance of secondary infection with Histoplasma capsulatum. J Immunol (2001) 0.93
Histoplasma capsulatum strain variation in both H antigen production and beta-glucosidase activity and overexpression of HAG1 from a telomeric linear plasmid. Infect Immun (1999) 0.90
Applying in vivo expression technology (IVET) to the fungal pathogen Histoplasma capsulatum. Microb Pathog (2000) 0.90
Cellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis. J Immunol (1984) 0.90
Molecular cloning, characterization and expression of the heat shock protein 60 gene from the human pathogenic fungus Paracoccidioides brasiliensis. Med Mycol (2001) 0.88
Transfer of protective immunity in murine histoplasmosis by a CD4+ T-cell clone. Infect Immun (1993) 0.86
Unexplained fever in burn patients due to cytomegalovirus infection. JAMA (1982) 0.84
Fulminant wound infection with Aeromonas hydrophila. South Med J (1980) 0.83
Recognition of Histoplasma capsulatum yeast-cell antigens by human lymphocytes and human T-cell clones. J Leukoc Biol (1992) 0.83
Immunomodulation in the mycoses. J Med Vet Mycol (1992) 0.82
Generation of disparate immunoregulatory factors in two inbred strains of mice with disseminated histoplasmosis. J Immunol (1982) 0.81
Pharmacological modulation of suppressor cell activity in mice with disseminated histoplasmosis. Infect Immun (1983) 0.81
Infection with Histoplasma capsulatum: Host-fungus interface. Rev Iberoam Micol (1998) 0.80
Interleukin-12 neutralization alters lung inflammation and leukocyte expression of CD80, CD86, and major histocompatibility complex class II in mice infected with Histoplasma capsulatum. Infect Immun (2000) 0.80
Type 1 and type 2 cytokines: from basic science to fungal infections. Med Mycol (1998) 0.80
Evolution of inflammatory response and cellular immune responses in a murine model of disseminated blastomycosis. Infect Immun (1985) 0.79
Impairment of granulomatous inflammatory response to Histoplasma capsulatum by inhibitors of angiotensin-converting enzyme. Infect Immun (1985) 0.78
Atypical mycobacterial lymphadenitis in an adult. Chest (1980) 0.77
Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate. Ann Pharmacother (1997) 0.75
Resolution of influenzal pneumonia. IMJ Ill Med J (1980) 0.75
Simultaneous infection with Blastomyces dermatitidis and Cryptococcus neoformans. Med Mycol (1998) 0.75